
Raluca Dinu
About Raluca Dinu
Raluca Dinu, age 51, is QTIH’s Chief Executive Officer and a Class III director, appointed CEO on March 12, 2024; she previously co-founded the company’s predecessor (GigCapital5) and served as President, CEO and Secretary since February 2021 . She holds a B.Sc. and Ph.D. in Solid State Condensed Matter Physics (University of Bucharest), an Executive MBA from Stanford, and a Corporate Director certificate from Harvard Business School (Audit and Compensation Committees, 2021; Making Corporate Boards More Effective, 2022) . Company performance for FY2024 included commercial revenue of $4.9 million, 12 scanners shipped, gross margin of 54%, and net loss of $9.0 million; TSR and EBITDA growth were not disclosed in the proxy . QTIH classifies Dinu as a non‑independent director; the Chairman role is separate and held by Avi Katz, who is married to Dinu, an important governance consideration for independence and oversight .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Integrated Device Technology (IDT) | VP & GM, Optical Interconnects | Apr 2017–May 2019 | Led optical interconnect business; drove alliances and operations |
| GigPeak (GigOptix) | EVP & COO; EVP Global Sales & Marketing; SVP Global Sales & Marketing | Apr 2016–Apr 2017; Aug 2015–Apr 2016; Dec 2014–Aug 2015 | Scaled operations; global go-to-market; M&A integration (GigPeak sold to IDT) |
| Lumera (Nasdaq: LMRA) | VP of Engineering | 2001–2008 | Engineering leadership prior to acquisition by GigPeak |
| Brazil-Photonics (JV with CPqD) | Board Director | Feb 2014–Sep 2017 | Oversight of joint venture in photonics; international expansion |
External Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| GigCapital2 → UpHealth, Inc. | CEO (GIG2); Director (continued after combination) | Aug 2019–Jun 2021 (CEO); Director since Mar 2019 | Led SPAC sponsor; post‑combination board role in digital health |
| GigCapital3 → Lightning eMotors | Director (GIG3); Co‑Chair post‑combination; resigned Oct 2021 | Feb 2020–Oct 2021 | SPAC sponsor role; early-stage EV commercial vehicles oversight |
| GigCapital4 → BigBear.ai (NYSE: BBAI) | CEO/President/Secretary (GIG4); Director until Mar 2024 | Dec 2020–Mar 2024 | Led AI/ML sponsor; board role through scale-up |
| GigCapital7 (Nasdaq: GIG) | Co‑founder; Director | Since May 2024 | PPE sponsor in TMT/AI/Cybersecurity/MedTech; IPO Aug 2024 |
| GigInternational1 (Nasdaq: GIW) | CEO/President/Secretary; Director | Mar 2021–Dec 2022 | EMEA-focused PPE; liquidated in Nov–Dec 2022 |
Fixed Compensation
| Metric | 2023 | 2024 |
|---|---|---|
| Base Salary ($) | — | $470,000 (per CEO Employment Agreement dated Mar 12, 2024) |
| Target Annual Bonus (% of base) | — | 65% of base salary |
| Special Achievement Bonus eligibility | — | Discretionary, Board‑determined for accretive transactions/special activities |
| Benefits/Perquisites | — | Standard executive benefits; up to 60 days PTO; business expense reimbursement |
Performance Compensation
| Component | Metric | Weighting | Target | Actual/Payout | Vesting |
|---|---|---|---|---|---|
| Annual Cash Incentive (2024) | Total Revenue | Not disclosed | Not disclosed | Determined after audit of FY2024; payout to be set by Compensation Committee | N/A |
| Annual Cash Incentive (2024) | Cash Balance | Not disclosed | Not disclosed | Determined after audit of FY2024; payout to be set by Compensation Committee | N/A |
| Stock Options (grant) | Time‑based stock options | N/A | 550,000 options | Grant date 7/3/2024; exercise price $0.748; grant-date fair value $0.47 per option | 1/3 vests on 2/15/2025; remaining 2/3 vest quarterly over two years; expire 7/3/2034 |
| Outstanding at FYE 2024 | Unexercisable options | N/A | — | 590,000 unexercisable; exercise price $0.748; expiration 7/3/2034 | Time‑based per schedule above |
Notes: Company policy does not backdate, time releases, or accelerate/delay equity grants to benefit stock price; equity program currently uses time-based options .
Equity Ownership & Alignment
| Ownership Detail | Value |
|---|---|
| Total beneficial ownership | 2,151,350 shares (includes derivatives exercisable within 60 days) |
| Ownership as % of outstanding | 7.2% (out of 28,710,144 shares outstanding as of Jul 16, 2025) |
| Options exercisable within 60 days | 411,875 shares |
| Options unexercisable (as of 12/31/2024) | 590,000 options @ $0.748; expire 7/3/2034 |
| Warrants exercisable within 60 days | 571,440 shares |
| Pledging/Hedging | Insider trading policy disclosed (Exhibit 19.1 to 2024 Annual Report); specific pledging status not disclosed |
| Ownership guidelines | Not disclosed in proxy |
Employment Terms
| Provision | Terms |
|---|---|
| Employment status | At‑will; initial CEO term 12 months from Mar 12, 2024, renewable by written agreement |
| Reporting | Reports to Board |
| Annual Bonus mechanics | Target = 65% of base; determined vs Board‑set objectives; payable within 2.5 months post‑FY |
| Special Achievement Bonus | Board discretion for accretive transactions/special activities; proposal structure considered in good faith |
| Equity grants | 550,000 shares under 2024 Plan; all outstanding unvested awards accelerate on change of control; if exercisable awards, exercise period remains for maximum permitted duration |
| Change‑of‑Control (CoC) | Single‑trigger acceleration of all outstanding unvested awards; Target Bonus for FY of CoC if not yet paid; lump sum = 2 years of base + average of prior two FYs’ Annual + Special Achievement Bonuses; potential excise tax equalization (gross‑up) to neutralize penalties |
| Termination w/o Cause or for Good Reason (no CoC) | Six months’ base in installments; pro‑rated final bonus; lump sum = 18 months’ base + 2x average of prior two FY CEO Bonuses (Annual + Special Achievement) |
| Death/Disability | Death: Final comp + 12 months’ base + Target Bonus for FY + beneficiary health/dental premiums; Disability: Final comp lump sum by Mar 15 of following year + pro‑rated bonus + beneficiary benefits |
| Cause termination | No severance beyond Final Compensation; equity governed by plan terms |
| COBRA/Benefits post‑CoC termination | Health/dental coverage for up to two years for Dinu and beneficiaries, subject to conditions |
| IP/Confidentiality | Proprietary Information and Inventions Agreement executed; Company indemnification per bylaws; D&O coverage provided |
Board Governance
- Board service: Class III director since 2024; current Board has seven members across three classes with staggered terms .
- Committee roles: Dinu is not listed as a member of Audit, Compensation, or Nominating & Corporate Governance committees in 2024; those committees are chaired by independent directors (Audit: Ross Taylor; Compensation: James Greene; Nominating: Prof. Zeev Weiner) .
- Independence: Board determined Dinu is not independent (executive officer), and notes spousal relationship with Chairman Avi Katz; independent directors are Taylor, Dickson, Greene, Weiner .
- Board attendance and executive sessions: Incumbent directors attended at least 75% of meetings; executive sessions are held regularly and presided over by the Chairman .
- Director compensation: Proxy reports director fees and option grants for non‑NEO directors; Dinu’s director compensation is not separately disclosed given her status as an NEO .
Compensation Structure Analysis
- Mix and performance linkage: 2024 program anchors cash bonus to two financial metrics (total revenue, cash balance) but does not disclose targets/weights; long‑term is time‑based options, implying retention focus more than strict performance vesting .
- Risk/red flags: Single‑trigger equity acceleration on CoC and inclusion of excise tax gross‑up increase payout certainty irrespective of post‑transaction performance; these are shareholder‑unfriendly features relative to double‑trigger market norms .
- Equity grant cadence: Grants in 2024 were first year post‑public listing; company states no backdating or timing manipulation of grants .
- Cash vs equity change: Initial CEO base set at $470,000 with equity grant of 550,000 options; year‑over‑year comparability limited due to leadership transition and listing status .
Related Party Transactions and Interlocks
- Spousal relationship: Drs. Katz (Chairman) and Dinu (CEO) are married; Board independence and related party review processes disclosed .
- Sponsor/affiliate financing: Various GigCapital‑related notes and lock‑up arrangements; registration rights and conversions detailed; while primarily company‑level, they reflect sponsor ecosystem ties where Dinu and Katz have roles .
- Policy oversight: Audit Committee pre‑approves related party transactions and oversees conflicts per charter .
Say‑on‑Pay and Shareholder Feedback
- QTIH is an emerging growth company and is exempt from say‑on‑pay votes and CEO pay ratio disclosures at this stage; voting outcomes for the 2025 meeting are reported via Form 8‑K, with proposals limited to director elections, auditor ratification, and reverse split authorization .
Performance & Track Record
- FY2024 highlights under Dinu’s leadership include commercial revenue of $4.9 million, 12 scanners shipped, and 54% gross margin; net loss was $9.0 million with detailed non‑cash/one‑time items; operating cash outflow was $10.0 million. TSR and EBITDA growth are not disclosed in the proxy .
Equity Vesting & Insider Selling Pressure
- Options vesting: One‑third vests on February 15, 2025, with remaining two‑thirds vesting quarterly over two years; this creates ongoing supply over eight quarters, which may contribute to periodic insider sales under Rule 10b5‑1 plans if adopted .
- Section 16 timeliness: 2024 Form 4s for July 3 grants were filed one–two days late due to July 4 holiday; a September 2024 distribution to Dinu from a fund was reported one day late .
Compensation Peer Group
- The Compensation Committee targets competitiveness with peer practices but does not disclose a specific peer group or targeted percentile in the proxy .
Expertise & Qualifications
- Technical and operating credentials in TMT, semiconductors, optical interconnects, and AI/ML sponsor leadership; advanced degrees in physics and an Executive MBA; Harvard Board education emphasizing audit/compensation governance .
Investment Implications
- Alignment: Meaningful beneficial ownership (7.2%) and substantial equity exposure via options and warrants align interests, but single‑trigger CoC acceleration and excise tax gross‑up dilute pay‑performance rigor and may inflate change‑of‑control payouts .
- Performance incentives: Near‑term cash metrics (revenue, cash balance) guide annual bonus, supporting liquidity and commercialization milestones; lack of disclosed targets/weights limits transparency for pay‑for‑performance assessment .
- Retention and supply: Eight‑quarter vesting cadence from Feb 2025 likely reduces near‑term retention risk while introducing potential selling pressure as tranches vest; monitor Rule 10b5‑1 plan activity and Form 4s for signaling .
- Governance: Dual‑role dynamic with Chairman spouse and CEO non‑independence elevates oversight risk; independence on key committees partially mitigates but warrants continued attention to related party reviews and board processes .